|
|
|
|
|
by __P
4333 days ago
|
|
If it was not 'for-profit' and public. It could be shared more freely. Meaning you'd ideally have a global effort towards drug R&D. This would easily dwarf any number the current US pharmaceuticals invest, or the NIH budget. Advances would be shared and make the cost of an advance cheaper. Also if it were open (globally) countries could be the checks and balances for each other. And no, pharma don't need marketing. Marketing is always used to trick people into buying things, or to create brand awareness, it's never about the good of the recipient. Dr's could simply have a database where they look up drugs and supporting material (i.e pull information rather than push marketing). |
|